name: Real time dynamic ultrasound of infant hips, with image documentation, requiring manipulation by physician


name: Limited real time static ultrasound of infant hips, with image documentation, requiring other qualified health care professional


name: Limited real time static ultrasound of infant hips, with image documentation, requiring physician


name: Ultrasound guided compression repair of blood vessel


name: Ultrasound guidance for vascular access with evaluation of potential access sites, documentation of selected vessel patency, and concurrent real time ultrasound visualization of vascular needle entry


name: Imaging supervision and interpretation of ultrasonic guidance for needle placement for aspiration


name: Targeted dynamic microbubble sonographic contrast characterization of initial noncardiac lesion


name: Targeted dynamic microbubble sonographic contrast characterization of each additional noncardiac lesion with separate injection


name: Unlisted diagnostic ultrasound procedure


name: Unlisted interventional ultrasound procedure


name: Computed tomography (CT) guidance for stereotactic localization


name: Radiological supervision and interpretation of computed tomography (CT) guidance for needle placement


name: Radiological supervision and interpretation of computed tomography (CT) guidance for needle placement for aspiration


name: Radiological supervision and interpretation of computed tomography (CT) guidance for needle placement for biopsy


name: Radiological supervision and interpretation of computed tomography (CT) guidance for needle placement for injection


name: Radiological supervision and interpretation of computed tomography (CT) guidance for needle placement of localization device


name: Computed tomography (CT) guidance and monitoring of parenchymal tissue ablation


name: Radiological supervision and interpretation of magnetic resonance imaging (MRI) guidance for needle placement


name: Radiological supervision and interpretation of magnetic resonance imaging (MRI) guidance for needle placement for aspiration


name: Radiological supervision and interpretation of magnetic resonance imaging (MRI) guidance for needle placement for biopsy


name: Radiological supervision and interpretation of magnetic resonance imaging (MRI) guidance for needle placement for injection


name: Radiological supervision and interpretation of magnetic resonance imaging (MRI) guidance for needle placement of localization device


name: Magnetic resonance imaging (MRI) guidance and monitoring of ablation of parenchymal tissue


name: Unilateral magnetic resonance imaging (MRI) of breast without contrast material


name: Bilateral magnetic resonance imaging (MRI) of breast, without contrast material


name: Unilateral magnetic resonance imaging (MRI) of breast without and with contrast material


name: Unilateral magnetic resonance imaging (MRI) of breast without and with contrast material, with computer-aided detection (CAD)


name: Bilateral magnetic resonance imaging (MRI) of breast without and with contrast material


name: Bilateral magnetic resonance imaging (MRI) of breast without and with contrast material, with computer-aided detection (CAD)


name: Radiological supervision and interpretation of mammary ductogram of single duct


name: Radiological supervision and interpretation of mammary galactogram of single duct


name: Radiological supervision and interpretation of mammary ductogram of multiple ducts


name: Radiological supervision and interpretation of mammary galactogram of multiple ducts


name: Bilateral diagnostic mammography with computer-aided detection (CAD)


name: Bilateral screening mammography with computer-aided detection (CAD)


name: Single view x-ray survey of multiple joints


name: Computed tomography (CT) bone mineral density study of axial skeleton


name: Computed tomography (CT) bone mineral density study of hips


name: Computed tomography (CT) bone mineral density study of pelvis


name: Computed tomography (CT) bone mineral density study of spine


name: Computed tomography (CT) bone mineral density study of spine, pelvis, and hips


name: Dual-energy x-ray absorptiometry (DXA) bone density study of hips


name: Dual-energy x-ray absorptiometry (DXA) bone density study of multiple sites of axial skeleton


name: Dual-energy x-ray absorptiometry (DXA) bone density study of pelvis


name: Dual-energy x-ray absorptiometry (DXA) bone density study of single site of axial skeleton


name: Dual-energy x-ray absorptiometry (DXA) bone density study of spine


name: Dual-energy x-ray absorptiometry (DXA) bone density study of appendicular skeleton


name: Dual-energy x-ray absorptiometry (DXA) bone density study of heel


name: Dual-energy x-ray absorptiometry (DXA) bone density study of radius


name: Dual-energy x-ray absorptiometry (DXA) bone density study of radius and wrist


name: Dual-energy x-ray absorptiometry (DXA) bone density study of radius, wrist, and heel


name: Dual-energy x-ray absorptiometry (DXA) bone density study of wrist


name: Dual-energy x-ray absorptiometry (DXA) bone density study of hips with vertebral fracture assessment


name: Dual-energy x-ray absorptiometry (DXA) bone density study of multiple sites of axial skeleton with vertebral fracture assessment


name: Dual-energy x-ray absorptiometry (DXA) bone density study of pelvis with vertebral fracture assessment


name: Dual-energy x-ray absorptiometry (DXA) bone density study of single site of axial skeleton with vertebral fracture assessment


name: Dual-energy x-ray absorptiometry (DXA) bone density study of spine with vertebral fracture assessment


name: Magnetic resonance imaging (MRI) of bone marrow blood supply


name: Dual-energy x-ray absorptiometry (DXA) bone density study of vertebra


name: Intermediate therapeutic radiology treatment planning for 2 areas of malignancy


name: Complex therapeutic radiology treatment planning


name: Complex therapeutic radiology treatment planning for 3 or more areas of malignancy


name: Intermediate therapeutic radiology simulation-aided field setting for 2 areas of malignancy


name: Complex therapeutic radiology simulation-aided field setting for 3 or more areas of malignancy


name: 3-dimensional (3D) therapeutic radiology simulation-aided field setting


name: 3-dimensional (3D) therapeutic radiology simulation-aided field setting with dose-volume histograms


name: Basic radiation dosimetry calculation, with central axis depth dose calculation, time dose fractionation, nominal standard dose, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of nonionizing radiation surface, and depth dose


name: Intensity modulated radiotherapy plan with dose-volume histograms for target and critical structure partial tolerance specifications


name: Simple brachytherapy isodose plan with basic dosimetry calculation


name: Intermediate brachytherapy isodose plan with basic dosimetry calculation


name: Complex brachytherapy isodose plan with basic dosimetry calculation


name: Design and construction of simple block for radiation oncology treatment


name: Design and construction of simple bolus for radiation oncology treatment


name: Design and construction of simple protective device for radiation oncology treatment


name: Design and construction of multiple bite blocks for radiation oncology treatment


name: Design and construction of multiple blocks for radiation oncology treatment


name: Design and construction of multiple stents for radiation oncology treatment


name: Design and construction of special bolus for radiation oncology treatment


name: Continuing medical physics consultation, with assessment of treatment parameters, quality assurance of dose delivery, and review of patient treatment documentation in support of the radiation oncologist


name: Design and construction of multileaf collimator devices (MLC) for intensity modulated radiation therapy (IMRT)


name: Complete single-session course of stereotactic radiosurgery of multiple cranial lesions using multisource Cobalt 60


name: Complete single-session course of stereotactic radiosurgery of single cranial lesion using multisource Cobalt 60


name: Delivery of single fraction of multifraction course of stereotactic body radiation therapy with image guidance


name: Guidance for localization of target volume for radiation delivery


name: Guidance for localization of target volume for radiation delivery with intrafraction tracking


name: Unlisted medical radiation dosimetry services


name: Unlisted medical radiation physics services


name: Unlisted medical radiation special services


name: Unlisted medical radiation treatment devices services


name: Stereotactic body radiation therapy treatment management of multifraction treatment course with image guidance


name: Stereotactic body radiation therapy treatment management with image guidance


name: Externally generated superficial hyperthermia, heating to depths 4.0 cm or less


name: Externally generated deep hyperthermia, heating to depths more than 4.0 cm


name: Hyperthermia generated by 5 or fewer interstitial probes


name: Simple intracavitary radiation source application


name: Simple intracavitary radiation source application of 1-4 sources


name: Intermediate intracavitary radiation source application


name: Complex intracavitary radiation source application


name: Remote afterloading high dose rate radionuclide surface brachytherapy for lesions less than 2.0 cm


name: Remote afterloading high dose rate radionuclide surface brachytherapy for lesions more than 2.0 cm and through multiple channels


name: Remote afterloading high dose rate radionuclide surface brachytherapy with basic dosimetry for lesions more than 2.0 cm and through multiple channels


name: Remote afterloading high dose rate radionuclide surface brachytherapy with basic dosimetry for multiple lesions


name: Remote afterloading high dose rate radionuclide interstitial brachytherapy with basic dosimetry through 1 channel


name: Remote afterloading high dose rate radionuclide intracavitary brachytherapy with basic dosimetry through 1 channel


name: Remote afterloading high dose rate radionuclide interstitial brachytherapy with basic dosimetry through 2-12 channels


name: Remote afterloading high dose rate radionuclide intracavitary brachytherapy with basic dosimetry through 2-12 channels


name: Remote afterloading high dose rate radionuclide interstitial brachytherapy with basic dosimetry through more than 12 channels


name: Remote afterloading high dose rate radionuclide intracavitary brachytherapy with basic dosimetry through more than 12 channels


name: Complex interstitial radiation source application of more than 10 sources, with supervision, handling, and loading of radiation source


name: Nuclear imaging of limited area for detection of thyroid carcinoma metastasis


name: Nuclear imaging for detection of thyroid carcinoma metastases with additional studies


name: Parathyroid planar imaging with single photon emission computed tomography (SPECT)


name: Parathyroid planar imaging with single photon emission computed tomography (SPECT) with subtraction


name: Parathyroid planar imaging with single photon emission computed tomography (SPECT) and concurrently acquired computed tomography (CT) for anatomical localization


name: Parathyroid planar imaging, including subtraction, with single photon emission computed tomography (SPECT) and concurrently acquired computed tomography (CT) for anatomical localization


name: Unlisted diagnostic nuclear medicine procedure for endocrine disorder


name: Nuclear imaging of bone marrow of whole body


name: Nuclear medicine study of blood and lymphatic systems


name: Unlisted diagnostic nuclear medicine hematopoietic, reticuloendothelial and lymphatic procedure


name: Nuclear imaging of hepatobiliary system with gallbladder


name: Nuclear imaging of hepatobiliary system with gallbladder with pharmacologic intervention


name: Nuclear imaging of hepatobiliary system with gallbladder with pharmacologic intervention and quantitative measurements


name: Nuclear gastric emptying with small bowel and colon transit study, multiple days


name: Administration of C-14 isotope and collection of breath test for analysis


name: Administration of C-14 isotopic urea breath test analysis


name: Unlisted diagnostic nuclear medicine gastrointestinal procedure


name: Nuclear imaging of bones and joints of whole body


name: Unlisted diagnostic nuclear medicine musculoskeletal procedure


name: Multiple nonimaging determinations of central cardiovascular hemodynamics


name: Multiple nonimaging determinations of central cardiovascular hemodynamics with exercise


name: Multiple nonimaging determinations of central cardiovascular hemodynamics with pharmacological intervention


name: Single nonimaging determination of central cardiovascular hemodynamics


name: Single nonimaging determination of central cardiovascular hemodynamics with exercise


name: Single nonimaging determination of central cardiovascular hemodynamics with pharmacological intervention


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation with evaluation of ejection fraction with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation with evaluation of ventricular wall motion and ejection fraction with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation with evaluation of ventricular wall motion with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation with evaluation of ejection fraction


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation with evaluation of ventricular wall motion


name: Single positron emission tomography (PET) myocardial imaging study for metabolic evaluation with evaluation of ventricular wall motion and ejection fraction


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ejection fraction, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ejection fraction, with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ejection fraction, with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion and ejection fraction, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion and ejection fraction, with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion and ejection fraction, with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion, with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion, with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ejection fraction, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ejection fraction, with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ejection fraction, with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion and ejection fraction, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion and ejection fraction, with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion and ejection fraction, with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion, with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion, with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with exercise stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with pharmacologic stress, with concurrently acquired computed tomography (CT) transmission scan


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies, at rest, with concurrently acquired computed tomography (CT) transmission scan


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ejection fraction, at rest


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ejection fraction, with exercise stress


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ejection fraction, with pharmacologic stress


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion and ejection fraction, at rest


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion and ejection fraction, with exercise stress


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion and ejection fraction, with pharmacologic stress


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion, at rest


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion, with exercise stress


name: Single positron emission tomography (PET) myocardial perfusion imaging study with evaluation of ventricular wall motion, with pharmacologic stress


name: Single positron emission tomography (PET) myocardial perfusion imaging study, at rest


name: Single positron emission tomography (PET) myocardial perfusion imaging study, with exercise stress


name: Single positron emission tomography (PET) myocardial perfusion imaging study, with pharmacologic stress


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ejection fraction, at rest and with exercise stress


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ejection fraction, at rest and with pharmacologic stress


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion and ejection fraction, at rest and with exercise stress


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion and ejection fraction, at rest and with pharmacologic stress


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion, at rest and with exercise stress


name: Multiple positron emission tomography (PET) myocardial perfusion imaging studies with evaluation of ventricular wall motion, at rest and with pharmacologic stress


name: Positron emission tomography (PET) combined myocardial perfusion imaging study and metabolic evaluation study using dual radiotracer


name: Positron emission tomography (PET) combined myocardial perfusion imaging study and metabolic evaluation study using dual radiotracer, with evaluation of ejection fraction


name: Positron emission tomography (PET) combined myocardial perfusion imaging study and metabolic evaluation study using dual radiotracer, with evaluation of ventricular wall motion


name: Positron emission tomography (PET) combined myocardial perfusion imaging study and metabolic evaluation study using dual radiotracer, with evaluation of ventricular wall motion and ejection fraction


name: Positron emission tomography (PET) combined myocardial perfusion imaging and metabolic evaluation study using dual radiotracer, with concurrently acquired computed tomography (CT) transmission scan


name: Positron emission tomography (PET) combined myocardial perfusion imaging and metabolic evaluation study using dual radiotracer, with evaluation of ejection fraction, with concurrently acquired computed tomography (CT) transmission scan


name: Positron emission tomography (PET) combined myocardial perfusion imaging and metabolic evaluation study using dual radiotracer, with evaluation of ventricular wall motion and ejection fraction, with concurrently acquired computed tomography (CT) transmission scan


name: Positron emission tomography (PET) combined myocardial perfusion imaging and metabolic evaluation study using dual radiotracer, with evaluation of ventricular wall motion, with concurrently acquired computed tomography (CT) transmission scan


name: Positron emission tomography (PET) absolute quantification of myocardial blood flow (AQMBF), at rest, and pharmacologic stress


name: Nuclear noncardiac vascular flow imaging


name: Single-photon emission computed tomography (SPECT) myocardial perfusion imaging study with stress


name: Single-photon emission computed tomography (SPECT) myocardial perfusion imaging study, at rest


name: Single-photon emission computed tomography (SPECT) myocardial perfusion imaging study, with exercise stress


name: Single-photon emission computed tomography (SPECT) myocardial perfusion imaging study, with pharmacologic stress


name: Multiple single-photon emission computed tomography (SPECT) myocardial perfusion imaging studies with stress


name: Multiple single-photon emission computed tomography (SPECT) myocardial perfusion imaging studies, at rest


name: Multiple single-photon emission computed tomography (SPECT) myocardial perfusion imaging studies, with exercise stress


name: Multiple single-photon emission computed tomography (SPECT) myocardial perfusion imaging studies, with pharmacologic stress


name: Bilateral venogram for venous thrombosis imaging


name: Planar and single photon emission computed tomography (SPECT) myocardial imaging


name: Planar and single photon emission computed tomography (SPECT) myocardial imaging with quantification


name: Planar infarct avid and single photon emission computed tomography (SPECT) myocardial imaging


name: Planar infarct avid and single photon emission computed tomography (SPECT) myocardial imaging with quantification


name: Single planar cardiac blood pool imaging study by first pass technique with exercise and pharmacological stress, wall motion study plus ejection fraction, with quantification


name: Single planar cardiac blood pool imaging study by first pass technique with exercise stress, wall motion study plus ejection fraction


name: Single planar cardiac blood pool imaging study by first pass technique with exercise stress, wall motion study plus ejection fraction, with quantification


name: Single planar cardiac blood pool imaging study by first pass technique with pharmacological stress, wall motion study plus ejection fraction


name: Single planar cardiac blood pool imaging study by first pass technique with pharmacological stress, wall motion study plus ejection fraction, with quantification


name: Single planar cardiac blood pool imaging study by first pass technique with stress, wall motion study plus ejection fraction


name: Single planar cardiac blood pool imaging study by first pass technique with stress, wall motion study plus ejection fraction, with quantification


name: Single planar cardiac blood pool imaging study by first pass technique, at rest, wall motion study plus ejection fraction


name: Single planar cardiac blood pool imaging study by first pass technique, at rest, wall motion study plus ejection fraction, with quantification


name: Single planar cardiac blood pool imaging study by first pass technique, with exercise and pharmacological stress, wall motion study plus ejection fraction


name: Multiple planar cardiac blood pool imaging studies by first pass technique with exercise and pharmacological stress, wall motion study plus ejection fraction


name: Multiple planar cardiac blood pool imaging studies by first pass technique with exercise and pharmacological stress, wall motion study plus ejection fraction, with quantification


name: Multiple planar cardiac blood pool imaging studies by first pass technique with exercise stress, wall motion study plus ejection fraction


name: Multiple planar cardiac blood pool imaging studies by first pass technique with exercise stress, wall motion study plus ejection fraction, with quantification


name: Multiple planar cardiac blood pool imaging studies by first pass technique with pharmacological stress, wall motion study plus ejection fraction


name: Multiple planar cardiac blood pool imaging studies by first pass technique with pharmacological stress, wall motion study plus ejection fraction, with quantification


name: Multiple planar cardiac blood pool imaging studies by first pass technique with stress, wall motion study plus ejection fraction


name: Multiple planar cardiac blood pool imaging studies by first pass technique with stress, wall motion study plus ejection fraction, with quantification


name: Multiple planar cardiac blood pool imaging studies by first pass technique, at rest and with stress, wall motion study plus ejection fraction


name: Multiple planar cardiac blood pool imaging studies by first pass technique, at rest and with stress, wall motion study plus ejection fraction, with quantification


name: Cardiac blood pool single photon emission computed tomography (SPECT) imaging, gated equilibrium study, at rest, with wall motion study plus ejection fraction


name: Cardiac blood pool single photon emission computed tomography (SPECT) imaging, gated equilibrium study, at rest, with wall motion study plus ejection fraction, with quantitative processing


name: Unlisted diagnostic nuclear medicine cardiovascular procedure


name: Quantitative differential pulmonary perfusion using imaging


name: Quantitative differential pulmonary perfusion and ventilation using aerosol using imaging


name: Quantitative differential pulmonary perfusion and ventilation using gas using imaging


name: Quantitative differential pulmonary perfusion and ventilation using imaging


name: Unlisted diagnostic nuclear medicine respiratory procedure


name: Static brain imaging with vascular flow imaging, minimum views


name: Positron emission tomography (PET) of brain for metabolic evaluation


name: Positron emission tomography (PET) of brain for perfusion evaluation


name: Unlisted diagnostic nuclear medicine nervous system procedure


name: Single kidney imaging morphology study with functional and vascular flow


name: Single kidney imaging morphology study with functional and vascular flow, with injection of angiotensin converting enzyme inhibitor


name: Single kidney imaging morphology study with functional and vascular flow, with injection of angiotensin converting enzyme inhibitor and diuretic


name: Single kidney imaging morphology study with functional and vascular flow, with injection of diuretic


name: Single kidney imaging morphology study with functional and vascular flow, with pharmacological intervention


name: Multiple kidney imaging morphology studies with functional and vascular flow, with injection of angiotensin converting enzyme inhibitor


name: Multiple kidney imaging morphology studies with functional and vascular flow, with injection of angiotensin converting enzyme inhibitor and diuretic


name: Multiple kidney imaging morphology studies with functional and vascular flow, with injection of diuretic


name: Multiple kidney imaging morphology studies with functional and vascular flow, with pharmacological intervention


name: Nonimaging radioisotopic kidney function study


name: Unlisted diagnostic nuclear medicine genitourinary procedure


name: Planar imaging of distribution of radiopharmaceutical agent in pelvis, single day


name: Planar imaging radiopharmaceutical localization of tumor in chest, single day


name: Planar imaging radiopharmaceutical localization of tumor in chest, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of tumor in head, single day


name: Planar imaging radiopharmaceutical localization of tumor in head, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of tumor in limited area, single day


name: Planar imaging radiopharmaceutical localization of tumor in limited area, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of tumor in neck, single day


name: Planar imaging radiopharmaceutical localization of tumor in neck, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of tumor in pelvis, single day


name: Planar imaging radiopharmaceutical localization of tumor in pelvis, with vascular flow and blood pool imaging, single day


name: Planar imaging radiopharmaceutical localization of tumor in entire body, single day


name: Planar imaging radiopharmaceutical localization of tumor, with vascular flow and blood pool imaging in entire body, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in head, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in head, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in limited area, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in limited area, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in neck, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in neck, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in chest, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in chest, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in head, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in head, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in limited area, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in limited area, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in neck, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in neck, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in head, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in head, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in limited area, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in limited area, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in neck, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in neck, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis, with vascular flow and blood pool imaging, single day


name: Planar radiopharmaceutical localization of tumor in entire body, multiple days


name: Planar radiopharmaceutical localization of tumor in entire body, with vascular flow and blood pool imaging, multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in chest, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in head, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in head, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in limited area, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in limited area, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in neck, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in neck, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agents in limited area, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in chest with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in chest, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in head, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in head, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in limited area, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in limited area, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in neck, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in neck, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in chest, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in head, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in head, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in limited area, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in limited area, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in neck, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in neck, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in minimum of 2 areas, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in minimum of 2 areas, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis and knees, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis and knees, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in single area, multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in single area, with vascular flow and blood pool imaging, multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in minimum of 2 areas, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in minimum of 2 areas, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis and knees, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis and knees, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in single area, multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in single area, with vascular flow and blood pool imaging, multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in minimum of 2 areas, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in minimum of 2 areas, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis and knees, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis and knees, with vascular flow and blood pool imaging, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in single area, multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in single area, with vascular flow and blood pool imaging, multiple days


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in minimum of 2 areas, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in minimum of 2 areas, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis and knees with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in pelvis and knees, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) imaging of distribution of radiopharmaceutical agent in single area, with concurrently acquired computed tomography (CT) transmission, multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in abdomen and pelvis with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in abdomen and pelvis, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in minimum of 2 areas with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in minimum of 2 areas, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis and knees with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in pelvis and knees, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of inflammation in single area, with concurrently acquired computed tomography (CT) transmission, multiple days


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in minimum of 2 areas with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in minimum of 2 areas, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis and knees in minimum of 2 areas, with vascular flow and blood pool imaging, with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in pelvis and knees with concurrently acquired computed tomography (CT) transmission, single day


name: Single photon emission computed tomography (SPECT) radiopharmaceutical localization of tumor in single area, with concurrently acquired computed tomography (CT) transmission, multiple days


name: Intravenous injection procedure for radiopharmaceutical localization by nonimaging probe study


name: Positron emission tomography (PET) imaging of chest


name: Positron emission tomography (PET) imaging of head


name: Positron emission tomography (PET) imaging of head and neck


name: Positron emission tomography (PET) imaging of limited area


name: Positron emission tomography (PET) imaging of neck


name: Positron emission tomography (PET) imaging of skull base to midthigh


name: Positron emission tomography (PET) imaging of whole body


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT)


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of chest


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of chest for attenuation correction and anatomical localization imaging


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of head


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of head and neck


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of head and neck for attenuation correction and anatomical localization imaging


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of head for attenuation correction and anatomical localization imaging


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of neck


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of neck for attenuation correction and anatomical localization imaging


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of skull base to midthigh for attenuation correction and anatomical localization imaging


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of whole body


name: Positron emission tomography (PET) with concurrently acquired computed tomography (CT) of whole body for attenuation correction and anatomical localization imaging


name: Unlisted diagnostic nuclear medicine procedure


name: Unlisted radiopharmaceutical therapy procedure


name: Blood test, basic group of blood chemicals (Calcium, ionized)


name: Basic metabolic panel with measurement of ionized calcium - Measurement of carbon dioxide


name: Basic metabolic panel with measurement of ionized calcium - Measurement of chloride


name: Basic metabolic panel with measurement of ionized calcium - Measurement of creatinine


name: Basic metabolic panel with measurement of ionized calcium - Measurement of glucose


name: Basic metabolic panel with measurement of ionized calcium - Measurement of ionized calcium


name: Basic metabolic panel with measurement of ionized calcium - Measurement of potassium


name: Basic metabolic panel with measurement of ionized calcium - Measurement of sodium


name: Basic metabolic panel with measurement of ionized calcium - Measurement of urea nitrogen (BUN)


name: Blood test, basic group of blood chemicals (Calcium, total)


name: Basic metabolic panel with measurement of total calcium - Measurement of carbon dioxide


name: Basic metabolic panel with measurement of total calcium - Measurement of chloride


name: Basic metabolic panel with measurement of total calcium - Measurement of creatinine


name: Basic metabolic panel with measurement of total calcium - Measurement of glucose


name: Basic metabolic panel with measurement of total calcium - Measurement of potassium


name: Basic metabolic panel with measurement of total calcium - Measurement of sodium


name: Basic metabolic panel with measurement of total calcium - Measurement of total calcium


name: Basic metabolic panel with measurement of total calcium - Measurement of urea nitrogen (BUN)


name: General health panel - Automated differential white blood cell count


name: General health panel - Buffy coat differential white blood cell count


name: General health panel - Complete automated differential blood count


name: General health panel - Manual differential white blood cell count


name: General health panel - Measurement of thyroid stimulating hormone


name: Electrolyte panel - Measurement of carbon dioxide


name: Electrolyte panel - Measurement of chloride


name: Electrolyte panel - Measurement of potassium


name: Electrolyte panel - Measurement of sodium


name: Comprehensive metabolic panel - Measurement of albumin


name: Comprehensive metabolic panel - Measurement of alkaline phosphatase


name: Comprehensive metabolic panel - Measurement of calcium


name: Comprehensive metabolic panel - Measurement of carbon dioxide


name: Comprehensive metabolic panel - Measurement of chloride


name: Comprehensive metabolic panel - Measurement of creatinine


name: Comprehensive metabolic panel - Measurement of glucose


name: Obstetric panel - Automated differential white blood cell (WBC) count


name: Obstetric panel - Buffy coat differential white blood cell (WBC) count


name: Obstetric panel - Complete automated blood count


name: Obstetric panel - Hepatitis B (HepB) surface antigen test


name: Obstetric panel - Manual differential white blood cell (WBC) count


name: Obstetric panel - Qualitative screening for syphilis antibody


name: Obstetric panel - Rubella antibody titer


name: Obstetric panel - Screening for red blood cell (RBC) antibody


name: Lipid panel - Direct measurement of high density cholesterol


name: Lipid panel - Measurement of triglycerides


name: Renal function panel - Measurement of albumin


name: Renal function panel - Measurement of blood urea nitrogen (BUN)


name: Renal function panel - Measurement of carbon dioxide


name: Renal function panel - Measurement of chloride


name: Renal function panel - Measurement of creatinine


name: Renal function panel - Measurement of glucose


name: Renal function panel - Measurement of inorganic phosphorus


name: Renal function panel - Measurement of potassium


name: Renal function panel - Measurement of sodium


name: Renal function panel - Measurement of total calcium


name: Acute hepatitis panel - Hepatitis A (HepA) IgM antibody test


name: Acute hepatitis panel - Hepatitis B (HepB) core IgM antibody test


name: Acute hepatitis panel - Hepatitis B (HepB) surface antigen test


name: Acute hepatitis panel - Hepatitis C (HepC) antibody test


name: Hepatic function panel - Hepatic function panel - Measurement of direct bilirubin


name: Hepatic function panel - Measurement of alanine amino transferase


name: Hepatic function panel - Measurement of albumin


name: Hepatic function panel - Measurement of alkaline phosphatase


name: Hepatic function panel - Measurement of aspartate amino transferase


name: Hepatic function panel - Measurement of total bilirubin


name: Hepatic function panel - Measurement of total protein


name: Obstetric panel including human immunodeficiency virus (HIV) testing


name: Measurement of total dipropylacetic acid


name: Measurement of gabapentin in whole blood


name: Measurement of procainamide with metabolites present


name: Testing for presence of drug, read by direct observation


name: Presumptive drug test using method read by direct optical observation only, per date of service


name: Presumptive drug test using method read by direct optical observation only, with sample validation, per date of service


name: Testing for presence of drug, read by instrument assisted observation


name: Presumptive drug test using method read by instrument-assisted direct optical observation, per date of service


name: Presumptive drug test using method read by instrument-assisted direct optical observation, with sample validation, per date of service


name: Presumptive drug test using instrument chemistry analyzer, per date of service


name: Presumptive drug test using instrument chemistry analyzer, with specimen validation, per date of service


name: Detection of 3 or more alcohol biomarkers


name: Measurement of 3 or more anabolic steroids


name: Measurement of single nonopioid analgesics


name: Measurement of 6 or more nonopioid analgesics


name: Antidepressants levels, 1 or 2 (serotonergic class)


name: Measurement of single serotonergic class antidepressant drug


name: Antidepressants levels, 3-5 (serotonergic class)


name: Antidepressants levels, 6 or more (serotonergic class)


name: Measurement of 6 or more serotonergic class antidepressant drugs


name: Antidepressants levels, 1 or 2 (tricyclic and other cyclicals)


name: Measurement of 2 cyclical antidepressant drugs


name: Measurement of 2 tricyclic antidepressant drugs


name: Measurement of single cyclical antidepressant drug


name: Measurement of single tricyclic antidepressant drug


name: Antidepressants levels, 3-5 (tricyclic and other cyclicals)


name: Measurement of 3-5 cyclical antidepressant drugs


name: Measurement of 3-5 tricyclic antidepressant drugs


name: Measurement of 6 or more cyclical antidepressant drugs


name: Measurement of 6 or more tricyclic antidepressant drugs


name: Measurement of antidepressants (not elsewhere specified)


name: Measurement of 7 or more antiepileptic drugs


name: Measurement of 7 or more antipsychotic drugs


name: Measurement of 1-3 synthetic cannabinoids


name: Measurement of 4-6 synthetic cannabinoids


name: Cannabinoids levels, synthetic, 7 or more


name: Measurement of 7 or more synthetic cannabinoids


name: Measurement of Methylenedioxyamphetamines (MDA, MDEA, MDMA)


name: Measurement of nonbenzodiazepine sedative hypnotics


name: Skeletal muscle relaxants levels, 1 or 2


name: Measurement of 2 skeletal muscle relaxants


name: Skeletal muscle relaxants levels, 3 or more


name: Measurement of 3 or more skeletal muscle relaxants


name: Qualitative measurement of 1-3 substances


name: Quantitative measurement of 1-3 substances


name: Qualitative measurement of 4-6 substances


name: Quantitative measurement of 4-6 substances


name: Drugs or substances measurement, 7 or more


name: Qualitative measurement of 7 or more drugs


name: Quantitative measurement of 7 or more drugs


name: Quantitative measurement of 7 or more substances


name: Adrenocorticotropic hormone (ACTH) stimulation panel for adrenal insufficiency


name: Adrenocorticotropic hormone (ACTH) stimulation panel for adrenal insufficiency - Measurement of cortisol


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 21- hydroxylase deficiency - Measurement of cortisol


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 21-hydroxylase deficiency


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 21-hydroxylase deficiency - Measurement of 17 hydroxyprogesterone


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 3 beta-hydroxydehydrogenase deficiency


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 3 beta-hydroxydehydrogenase deficiency - Measurement of 17 hydroxypregnenolone


name: Adrenocorticotropic hormone (ACTH) stimulation panel for 3 beta-hydroxydehydrogenase deficiency - Measurement of cortisol


name: Aldosterone suppression evaluation panel - Measurement of aldosterone


name: Aldosterone suppression evaluation panel - Measurement of renin


name: Calcitonin stimulation panel - Measurement of calcitonin


name: Corticotropic releasing hormone (CRH) stimulation panel - Measurement of adrenocorticotropic hormone (ACTH)


name: Corticotropic releasing hormone (CRH) stimulation panel - Measurement of cortisol


name: Chorionic gonadotropin stimulation panel for testosterone response - Measurement of testosterone response


name: Chorionic gonadotropin stimulation panel; estradiol response This panel must include the following: Estradiol, total (82670 x 2 on 3 pooled blood samples)


name: Renal vein renin stimulation panel - Measurement of renin


name: Peripheral vein renin stimulation panel - Measurement of renin


name: Combined rapid anterior pituitary evaluation panel - Measurement of adrenocorticotropic hormone (ACTH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of cortisol


name: Combined rapid anterior pituitary evaluation panel - Measurement of follicle stimulating hormone (FSH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of human growth hormone (HGH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of luteinizing hormone (LH)


name: Combined rapid anterior pituitary evaluation panel - Measurement of prolactin


name: Combined rapid anterior pituitary evaluation panel - Measurement of thyroid stimulating hormone (TSH)


name: 48 hour dexamethasone suppression panel - Measurement of cortisol


name: 48 hour dexamethasone suppression panel - Measurement of free cortisol in urine


name: 48 hour dexamethasone suppression panel - Volume measurement for timed collection of urine


name: Glucagon tolerance panel for insulinoma - Measurement of glucose


name: Glucagon tolerance panel for insulinoma - Measurement of insulin


name: Glucagon tolerance panel for pheochromocytoma - Measurement of fractionated catecholamines


name: Gonadotropin releasing hormone stimulation panel - Measurement of follicle stimulating hormone (FSH)


name: Gonadotropin releasing hormone stimulation panel - Measurement of luteinizing hormone (LH)


name: Growth hormone stimulation panel - Measurement of human growth hormone (HGH)


name: Growth hormone suppression panel - Measurement of glucose


name: Growth hormone suppression panel - Measurement of human growth hormone (HGH)


name: Insulin-induced C-peptide suppression panel - Measurement of C-peptide


name: Insulin-induced C-peptide suppression panel - Measurement of glucose


name: Insulin-induced C-peptide suppression panel - Measurement of insulin


name: Insulin tolerance panel for adrenocorticotropic hormone (ACTH) insufficiency


name: Insulin tolerance panel for adrenocorticotropic hormone (ACTH) insufficiency - Measurement of cortisol


name: Insulin tolerance panel for adrenocorticotropic hormone (ACTH) insufficiency - Measurement of glucose


name: Insulin tolerance panel for growth hormone deficiency - Measurement of glucose


name: Insulin tolerance panel for growth hormone deficiency - Measurement of human growth hormone (HGH)


name: Metyrapone panel - Measurement of 11 deoxycortisol


name: Metyrapone panel - Measurement of cortisol


name: 1 hour thyrotropin releasing hormone (TRH) stimulation panel


name: 1 hour thyrotropin releasing hormone (TRH) stimulation panel - Measurement of thyroid stimulating hormone


name: 2 hour thyrotropin releasing hormone (TRH) stimulation panel


name: 2 hour thyrotropin releasing hormone (TRH) stimulation panel - Measurement of thyroid stimulating hormone (TSH)


name: Manual urinalysis test with examination using microscope, non-automated


name: Qualitative urinalysis (except immunoassay)


name: Semiquantitative urinalysis (except immunoassay)


name: Bacteriuria screen (except by culture or dipstick)


name: Human Platelet Antigen 1 genotyping (HPA-1), integrin, beta 3 [platelet glycoprotein IIIa] (ITGB3), antigen CD61 [GPIIIa]) gene analysis for detection of HPA-1a/b (L33P) common variant


name: Human Platelet Antigen 2 genotyping (HPA-2), glycoprotein Ib [platelet], alpha polypeptide [GPIba] (GP1BA) gene analysis for detection of HPA-2a/b (T145M) common variant


name: Human Platelet Antigen 3 genotyping (HPA-3), integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex] (ITGA2B), antigen CD41 [GPIIb] (ITGA2B) gene analysis for detection of HPA-3a/b (I843S) common variant


name: Human Platelet Antigen 4 genotyping (HPA-4), integrin, beta 3 [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb] (ITGB3) gene analysis for detection of HPA-4a/b (R143Q) common variant


name: Isocitrate dehydrogenase 2 (NADP+P), mitochondrial (IDH2) gene analysis for detection of R172M variant


name: Breast cancer 1 and 2 (BRCA1, BRCA2) full sequence gene analysis and full analysis for detection of deletion and duplication variants


name: Breast cancer 1 and 2 (BRCA1, BRCA2) full analysis for detection of deletion and duplication variants


name: Breast cancer 1 (BRCA1) full analysis for detection of deletion and duplication variants


name: Breast cancer 2 (BRCA2) full analysis for detection of deletion and duplication variants


name: CCND1/IGH (t(11;14)) (eg, mantle cell lymphoma) translocation analysis, major breakpoint, qualitative and quantitative, if performed


name: Gene analysis (CCND1/IGH (t(11;14))) translocation analysis


name: CCND1/IGH (t(11;14)) qualitative and quantitative gene analysis for detection of translocation of major breakpoint


name: CCND1/IGH (t(11;14)) qualitative gene analysis for detection of translocation of major breakpoint


name: ABL proto-oncogene 1, nonreceptor tyrosine kinase (ABL1) gene analysis for detection of variants in the kinase domain


name: Ataxin 7 (ATXN7) gene analysis for detection of abnormal alleles


name: Ataxin 8 opposite strand [nonprotein coding] (ATXN8OS) gene analysis for detection of abnormal alleles


name: NTRK1 (neurotrophic receptor tyrosine kinase 1) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 1) translocation analysis


name: Neurotrophic receptor tyrosine kinase 1 (NTRK1) gene analysis for detection of translocation


name: NTRK2 (neurotrophic receptor tyrosine kinase 2) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 2) translocation analysis


name: Neurotrophic receptor tyrosine kinase 2 (NTRK2) gene analysis for detection of translocation


name: NTRK3 (neurotrophic receptor tyrosine kinase 3) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 3) translocation analysis


name: Neurotrophic receptor tyrosine kinase 3 (NTRK3) gene analysis for detection of translocation


name: NTRK (neurotrophic receptor tyrosine kinase 1, 2, and 3) (eg, solid tumors) translocation analysis


name: Gene analysis (neurotrophic receptor tyrosine kinase 1, 2, and 3) translocation analysis


name: Neurotrophic receptor tyrosine kinase 1,2, and 3 (NTRK1, 2, and 3) gene analysis for detection of translocation


name: B-Raf proto-oncogene, serine/threonine kinase (BRAF) gene analysis for detection of V600E variant


name: Cystic fibrosis transmembrane conductance regulator (CFTR) gene analysis for detection of deletion and duplication variants


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *2 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *3 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *4 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *5 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *6 variant


name: Cytochrome P450, family 3, subfamily A, member 5 (CYP3A5) gene analysis for detection of *7 variant


name: Bruton's tyrosine kinase (BTK) gene analysis for detection of C481F variant


name: Bruton's tyrosine kinase (BTK) gene analysis for detection of C481R variant


name: Bruton's tyrosine kinase (BTK) gene analysis for detection of C481S variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of G719A variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of G719S variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of L858R variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of L861Q variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of T790M variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of common variant


name: Epidermal growth factor receptor (EGFR) gene analysis for detection of exon 19 LREA deletion variant


name: Fanconi anemia, complementation group C (FANCC) gene analysis for detection of IVS4+4A>T variant


name: Fanconi anemia, complementation group C (FANCC) gene analysis for detection of common variant


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant of exon 14


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant of exon 15


name: Fms-related tyrosine kinase 3 (FLT3) gene analysis for detection of internal tandem duplication (ITD) variant of exons 14 and 15


name: Gap junction protein, beta 2, 26kDa, connexin 26 (GJB2) full gene sequence analysis


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of 1278insTATC variant


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of 1278insTATC, 1421+1G>C, and G269S variants


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of 1421+1G>C variant


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of G269S variant


name: Hexosaminidase A [alpha polypeptide] (HEXA) gene analysis for detection of common variant


name: Comparative analysis using short tandem repeat (STR) marker in patient and comparative buccal swab for posttransplant recipient germline and donor testing


name: Comparative analysis using short tandem repeat (STR) marker in patient and comparative germline tissue specimen for posttransplant recipient germline and donor testing


name: Comparative analysis using short tandem repeat (STR) marker in patient and comparative specimen for pretransplant recipient and donor germline testing


name: Comparative analysis using short tandem repeat (STR) marker in patient and donor specimen


name: Comparative analysis using Short Tandem Repeat (STR) markers of patient and specimen, each additional specimen


name: Comparative analysis using short tandem repeat (STR) marker, each additional specimen


name: Chimerism analysis post transplantation, with cell selection


name: Chimerism analysis in post transplantation specimen with cell selection and comparison to baseline analysis and CD3-positive T cell selection


name: Chimerism analysis in post transplantation specimen with cell selection and comparison to baseline analysis and CD33-positive myeloid cell selection


name: Chimerism analysis in post transplantation specimen with cell selection and comparison to baseline analysis and cell selection


name: Huntingtin (HTT) gene analysis for detection of abnormal alleles


name: Huntington disease gene analysis for detection of abnormal alleles


name: Huntingtin (HTT) gene analysis for characterization of alleles


name: Kirsten rat sarcoma viral oncogene (KRAS) gene analysis for detection of variant in codon 12


name: Kirsten rat sarcoma viral oncogene (KRAS) gene analysis for detection of variant in codon 13


name: Kirsten rat sarcoma viral oncogene (KRAS) gene analysis for detection of variant in exon 2


name: Kirsten rat sarcoma viral oncogene homolog (KRAS) gene analysis for additional variants


name: IGH@/BCL2 (t(14;18)) (eg, follicular lymphoma) translocation analysis, major breakpoint region (MBR) and minor cluster region (mcr) breakpoints, qualitative or quantitative


name: Gene analysis (IGH@/BCL2 (t(14;18)) translocation analysis


name: IGH@/BCL2 (t(14;18)) qualitative gene analysis for detection of translocation of major breakpoint region and minor cluster breakpoints


name: IGH@/BCL2 (t(14;18)) quantitative gene analysis for detection


name: JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) targeted sequence analysis (eg, exons 12 and 13)


name: Gene analysis (Janus kinase 2) targeted sequence analysis


name: Janus kinase 2 (JAK2) targeted sequence gene analysis


name: Janus kinase 2 (JAK2) targeted sequence gene analysis of exons 12, 13


name: Test for detecting genes associated with colon cancer, promoter methylation analysis


name: MutL homolog 1, colon cancer, nonpolyposis type 2 (MLH1) gene analysis for detection of promoter methylation variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *2 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *3 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *4 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *5 variant


name: Nudix hydrolase 15 (NUDT15) gene analysis for detection of *6 variant


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exon 20


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exon 7


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exon 9


name: Phosphatidylinositol-4, 5-biphosphate 3-kinase, catalytic subunit alpha (PIK3CA) targeted gene sequence analysis of exons 7, 9, and 20


name: Measurement of prostate cancer antigen 3 [nonprotein coding] and kallikrein-related peptidase 3 [prostate specific antigen] (PCA3/KLK3) ratio


name: Platelet-derived growth factor receptor, alpha polypeptide (PDGFRA) targeted gene sequence analysis


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, common breakpoints


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, intron 3 and intron 6 breakpoints


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, common breakpoints


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, intron 3 and intron 6 breakpoints


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single breakpoint


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single exon 6 breakpoint


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 3 breakpoint


name: Qualitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 6 breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single exon 6 breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 3 breakpoint


name: Quantitative promyelocytic leukemia/retinoic acid receptor alpha (PML/RARalpha) translocation analysis, single intron 6 breakpoint


name: Postmeiotic segregation increased 2 [S. cerevisiae] (PMS2) gene analysis for detection of known familial variant


name: Postmeiotic segregation increased 2 [S. cerevisiae] (PMS2) gene analysis for detection of deletion and duplication variants


name: Phosphatase and tensin homolog (PTEN) gene analysis for detection of deletion and duplication variants


name: Peripheral myelin protein 22 (PMP22) gene analysis for detection of deletion and duplication variants


name: Small nuclear ribonucleoprotein polypeptide N and ubiquitin protein ligase E3A (SNRPN/UBE3A) analysis for detection of methylated variant


name: MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis


name: MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; common variants (eg, W515A, W515K, W515L, W515R)


name: Gene analysis (MPL proto-oncogene, thrombopoietin receptor) for detection of common variants


name: MPL proto-oncogene, thrombopoietin receptor (MLP) gene analysis for detection of common variants


name: MPL proto-oncogene, thrombopoietin receptor (MLP) gene analysis for detection of common variants W515A, W515K, W515L, W515R


name: MPL (MPL proto-oncogene, thrombopoietin receptor) (eg, myeloproliferative disorder) gene analysis; sequence analysis, exon 10


name: Gene analysis (MPL proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10


name: MPL proto-oncogene, thrombopoietin receptor (MLP) sequence gene analysis of exon 10


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using amplification method


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using polymerase chain reaction method


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using Southern blot method


name: T cell antigen receptor, beta (TRB@) gene rearrangement analysis for detection of abnormal clonal population, using direct probe method


name: Telomerase reverse transcriptase (TERT) targeted gene sequence analysis of promoter region


name: SF3B1 (splicing factor [3b] subunit B1) (eg, myelodysplastic syndrome/acute myeloid leukemia) gene analysis, common variants (eg, A672T, E622D, L833F, R625C, R625L)


name: Gene analysis (splicing factor [3b] subunit B1) for detection of common variants


name: Splicing factor [3b] subunit B1) (SF3B1) gene analysis for detection of common variants


name: Splicing factor [3b] subunit B1) (SF3B1) gene analysis for detection of common variants A672T, E622D, L833F, R625C, R625L


name: SRSF2 (serine and arginine-rich splicing factor 2) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (eg, P95H, P95L)


name: Gene analysis (serine and arginine-rich splicing factor 2) for detection of common variants


name: Serine and arginine-rich splicing factor 2 (SRSF2) gene analysis for detection of common variants


name: Serine and arginine-rich splicing factor 2 (SRSF2) gene analysis for detection of common variants P95H, P95L


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; full gene sequence


name: Gene analysis (tumor protein 53) full sequence analysis


name: Tumor protein 53 (TP53) full sequence gene analysis


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; targeted sequence analysis (eg, 4 oncology)


name: Gene analysis (tumor protein 53) targeted sequence analysis


name: Tumor protein 53 (TP53) targeted sequence gene analysis


name: Tumor protein 53 (TP53) targeted sequence gene analysis of 4 oncology


name: TP53 (tumor protein 53) (eg, Li-Fraumeni syndrome) gene analysis; known familial variant


name: Gene analysis (tumor protein 53) targeted sequence analysis for detection of known familial variant


name: Tumor protein 53 (TP53) gene analysis for detection of known familial variant


name: Vitamin K epoxide reductase complex, subunit 1 (VKORC1) gene analysis for detection of -1639G>A variant


name: Vitamin K epoxide reductase complex, subunit 1 (VKORC1) gene analysis for detection of -c173+1000C>T variant


name: U2AF1 (U2 small nuclear RNA auxiliary factor 1) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variants (eg, S34F, S34Y, Q157R, Q157P)


name: Gene analysis (U2 small nuclear RNA auxiliary factor 1) for detection of common variants


name: U2 small nuclear RNA auxiliary factor 1 (U2AF1) gene analysis for detection of common variants


name: U2 small nuclear RNA auxiliary factor 1 (U2AF1) gene analysis for detection of common variants S34F, S34Y, Q157R, Q157


name: ZRSR2 (zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2) (eg, myelodysplastic syndrome, acute myeloid leukemia) gene analysis, common variant(s) (eg, E65fs, E122fs, R448fs)


name: Gene analysis (zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2) for detection of common variants


name: Zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2 (ZRSR2) gene analysis for detection of common variants


name: Zinc finger CCCH-type, RNA binding motif and serine/arginine-rich 2 (ZRSR2) gene analysis for detection of common variants E65fs, E122fs, R448fs


name: Hemoglobin, subunit beta (HBB) gene analysis for detection of HbC, HbE, and HbS variants


name: Complete low resolution human leukocyte antigen (HLA) Class I typing of HLA-A, HLA-B, and HLA-C


name: Low resolution human leukocyte antigen (HLA) Class I typing of single locus


name: Low resolution human leukocyte antigen (HLA) Class I typing of each antigen equivalent


name: Low resolution human leukocyte antigen (HLA) Class II typing of HLA-DRB1


name: Low resolution human leukocyte antigen (HLA) Class II typing of HLA-DRB3/4/5


name: Low resolution human leukocyte antigen (HLA) Class II typing of each locus


name: Low resolution human leukocyte antigen (HLA) Class II typing of each antigen equivalent


name: High resolution human leukocyte antigen (HLA) Class I and II typing of HLA-A, HLA-B, HLA-C,and HLA-DRB1


name: Complete high resolution human leukocyte antigen (HLA) Class I typing of HLA-A, HLA-B, and HLA-C


name: High resolution human leukocyte antigen (HLA) Class I typing of 1 locus


name: High resolution human leukocyte antigen (HLA) Class I typing of 1 allele


name: High resolution human leukocyte antigen (HLA) Class I typing of 1 allele group


name: High resolution human leukocyte antigen (HLA) Class II typing of 1 locus


name: High resolution human leukocyte antigen (HLA) Class II typing of HLA-DRB3/4/5


name: High resolution human leukocyte antigen (HLA) Class II typing of 1 allele group


name: High resolution human lymphocyte antigen Class II typing of 1 allele


name: Molecular pathology procedure, Level 1 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant


name: Molecular pathology procedure, Level 1 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin II receptor, type 1 (AGTR1) gene analysis for detection of 1166A>C variant


name: Molecular pathology procedure, Level 1 - Angiotensin II receptor, type 1 (AGTR1) gene analysis for detection of 1166A>C variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin II receptor, type 1 (AGTR1) gene analysis for detection of 1166A>C variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of deletion variant


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of deletion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of deletion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion and deletion variants


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion and deletion variants using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion and deletion variants using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion variant


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Angiotensin converting enzyme (ACE) gene analysis for detection of insertion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA) gene analysis for detection of Y438N variant


name: Molecular pathology procedure, Level 1 - Branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA) gene analysis for detection of Y438N variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Branched chain keto acid dehydrogenase E1, alpha polypeptide (BCKDHA) gene analysis for detection of Y438N variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Chemokine C-C motif receptor 5 (CCR5) gene analysis for detection of 32-bp deletion mutation/794 825del32 deletion


name: Molecular pathology procedure, Level 1 - Chemokine C-C motif receptor 5 (CCR5) gene analysis for detection of 32-bp deletion mutation/794 825del32 deletion using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Chemokine C-C motif receptor 5 (CCR5) gene analysis for detection of 32-bp deletion mutation/794 825del32 deletion using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Clarin 1 (CLRN1) gene analysis for detection of N48K variant


name: Molecular pathology procedure, Level 1 - Clarin 1 (CLRN1) gene analysis for detection of N48K variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Clarin 1 (CLRN1) gene analysis for detection of N48K variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor 2 (F2) gene analysis for detection of 1199G>A variant


name: Molecular pathology procedure, Level 1 - Coagulation factor 2 (F2) gene analysis for detection of 1199G>A variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor 2 (F2) gene analysis for detection of 1199G>A variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor V (F5) gene analysis for detection of HR2 variant


name: Molecular pathology procedure, Level 1 - Coagulation factor V (F5) gene analysis for detection of HR2 variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor V (F5) gene analysis for detection of HR2 variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor VII (F7) gene analysis for detection of R353Q variant


name: Molecular pathology procedure, Level 1 - Coagulation factor VII (F7) gene analysis for detection of R353Q variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor VII (F7) gene analysis for detection of R353Q variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Coagulation factor XIII, B polypeptide (F13B) gene analysis for detection of V34L variant


name: Molecular pathology procedure, Level 1 - Coagulation factor XIII, B polypeptide (F13B) gene analysis for detection of V34L variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Coagulation factor XIII, B polypeptide (F13B) gene analysis for detection of V34L variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fibrinogen beta chain (FGB) gene analysis for detection of -455G>A variant


name: Molecular pathology procedure, Level 1 - Fibrinogen beta chain (FGB) gene analysis for detection of -455G>A variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fibrinogen beta chain (FGB) gene analysis for detection of -455G>A variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 1 (FGFR1) gene analysis for detection of P252R variant


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 1 (FGFR1) gene analysis for detection of P252R variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 1 (FGFR1) gene analysis for detection of P252R variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of P250R variant


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of P250R variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fibroblast growth factor receptor 3 (FGFR3) gene analysis for detection of P250R variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Fukutin (FKTN) gene analysis for detection of retrotransposon insertion variant


name: Molecular pathology procedure, Level 1 - Fukutin (FKTN) gene analysis for detection of retrotransposon insertion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Fukutin (FKTN) gene analysis for detection of retrotransposon insertion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Gene analysis for detection of single germline variant


name: Molecular pathology procedure, Level 1 - Gene analysis for detection of single germline variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Gene analysis for detection of single germline variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosamine kinase (GNE) gene analysis for detection of M712T variant


name: Molecular pathology procedure, Level 1 - Glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosamine kinase (GNE) gene analysis for detection of M712T variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Glucosamine [UDP-N-acetyl]-2-epimerase/N-acetylmannosamine kinase (GNE) gene analysis for detection of M712T variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Isovaleryl-CoA dehydrogenase (IVD) gene analysis for detection of A282V variant


name: Molecular pathology procedure, Level 1 - Isovaleryl-CoA dehydrogenase (IVD) gene analysis for detection of A282V variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Isovaleryl-CoA dehydrogenase (IVD) gene analysis for detection of A282V variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Lactase-phlorizin hydrolase (LCT) gene analysis for detection of 13910 C>T variant


name: Molecular pathology procedure, Level 1 - Lactase-phlorizin hydrolase (LCT) gene analysis for detection of 13910 C>T variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Lactase-phlorizin hydrolase (LCT) gene analysis for detection of 13910 C>T variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Nebulin (NEB) gene analysis for detection of exon 55 deletion variant


name: Molecular pathology procedure, Level 1 - Nebulin (NEB) gene analysis for detection of exon 55 deletion variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Nebulin (NEB) gene analysis for detection of exon 55 deletion variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Protocadherin-related 15 (PCDH15) gene analysis for detection of R245X variant


name: Molecular pathology procedure, Level 1 - Protocadherin-related 15 (PCDH15) gene analysis for detection of R245X variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Protocadherin-related 15 (PCDH15) gene analysis for detection of R245X variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - SERPINE1 (serpine peptidase inhibitor clade E, member 1, plasminogen activator inhibitor -1, PAI-1) gene analysis for detection of 4G variant


name: Molecular pathology procedure, Level 1 - SERPINE1 (serpine peptidase inhibitor clade E, member 1, plasminogen activator inhibitor -1, PAI-1) gene analysis for detection of 4G variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - SERPINE1 (serpine peptidase inhibitor clade E, member 1, plasminogen activator inhibitor -1, PAI-1) gene analysis for detection of 4G variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Sex determining region Y (SRY) gene analysis


name: Molecular pathology procedure, Level 1 - Sex determining region Y (SRY) gene analysis using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Sex determining region Y (SRY) gene analysis using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Soc-2 suppressor of clear homolog (SHOC2) gene analysis for detection of S2G variant


name: Molecular pathology procedure, Level 1 - Soc-2 suppressor of clear homolog (SHOC2) gene analysis for detection of S2G variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Soc-2 suppressor of clear homolog (SHOC2) gene analysis for detection of S2G variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 1 - Torsin family 1, member A [torsin A] (TOR1A) gene analysis for detection of 907_909delGAG (904_906delGAG) variant


name: Molecular pathology procedure, Level 1 - Torsin family 1, member A [torsin A] (TOR1A) gene analysis for detection of 907_909delGAG (904_906delGAG) variant using melt curve analysis method


name: Molecular pathology procedure, Level 1 - Torsin family 1, member A [torsin A] (TOR1A) gene analysis for detection of 907_909delGAG (904_906delGAG) variant using restriction enzyme digestion method


name: Molecular pathology procedure, Level 2 - ABL prot-oncogene 1, non-receptor tyrosine kinase (ABL 1) gene analysis for detection of T313I variant


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of F1388del variant


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of c.3898-9G>A (c.3992-9G>A) and F1388del variants


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of c.3898-9G>A (c.3992-9G>A) variant


name: Molecular pathology procedure, Level 2 - ATP-binding cassette, sub-family C [CFTR/MRP], member 8 (ABCC8) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E and Y42H variants


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of K304E variant


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of Y42H variant


name: Molecular pathology procedure, Level 2 - Acyl-CoA dehydrogenase, C-4 to C-12 straight chain, MCAD (ACADM) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of G16R and Q27E variants


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of G16R variant


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of Q27E variant


name: Molecular pathology procedure, Level 2 - Adrenergic beta-2 receptor surface (ADRB2) gene analysis for detection of common variant


name: Molecular pathology procedure, Level 2 - Apolipoprotein B (APOB) gene analysis for detection of R3500Q and R3500W variants


name: Molecular pathology procedure, Level 2 - Apolipoprotein B (APOB) gene analysis for detection of R3500Q variant